Rheumatologic Toxicities

Rheumatologic Toxicities is a clinical construct referring to immune-mediated adverse events characterized by inflammatory musculoskeletal manifestations, such as arthritis, myositis, or sicca syndrome, that arise secondary to immune checkpoint inhibitor therapy.

127

Publications

5.7K

Citations

538

Authors

160

Institutions

Publications per year

2017–2026

15

Variants

Rheumatologic Immune-related Adverse EventsRheumatologic Iraes

Authors

538

  1. GS
    G S Alarcón

    University of Alabama at Birmingham, United States

    4 publications · 198 citations

    4

    h-index

  2. RH
    R. H. Waring

    University of Birmingham, United Kingdom

    3 publications · 172 citations

    3

    h-index

  3. JF
    James F. Fries

    Stanford University, United States

    3 publications · 135 citations

    3

    h-index

  4. PW
    Patricia W. Spitz

    Stanford University, United States

    2 publications · 253 citations

    2

    h-index

  5. BO
    Bruce O. Barger

    University of Alabama at Birmingham, United States

    2 publications · 124 citations

    2

    h-index

1–5 of 538

Venues

  1. PubMed

    Repository · 37 publications · 1.7K citations

    24

    h-index

  2. Annals of the Rheumatic Diseases

    ARD · 9 publications · 455 citations

    9

    h-index

  3. Lara D. Veeken

    9 publications · 303 citations

    9

    h-index

  4. Arthritis & Rheumatism

    8 publications · 564 citations

    8

    h-index

  5. Journal of the American Medical Association

    5 publications · 194 citations

    5

    h-index

1–5